California's new mental health court rolls out to high expectations and uncertainty
An alternative mental health court program designed to fast-track people with untreated schizophrenia into housing and medical care is starting in San Francisco and six other California counties (Source: ABC News: Health)
Source: ABC News: Health - October 2, 2023 Category: Consumer Health News Tags: Health Source Type: news

Polygenic Overlap Detected for Schizophrenia, CVD Risk
FRIDAY, Sept. 29, 2023 -- For individuals with schizophrenia, there is a genetic propensity for smoking and a reduced risk for obesity, according to a study published online Sept. 27 in the American Journal of Psychiatry. Linn R ødevand, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 29, 2023 Category: Pharmaceuticals Source Type: news

Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia
BOSTON--(BUSINESS WIRE)--Sep. 28, 2023-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 28, 2023 Category: Drugs & Pharmacology Source Type: news

Substance-Induced Psychosis Linked to Schizophrenia Risk Substance-Induced Psychosis Linked to Schizophrenia Risk
Nearly 20% of individuals who visited the ER for substance-induced psychosis were diagnosed with a schizophrenia spectrum disorder within 3 years, results of a large population-based study show.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 28, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news

New Insight Into Genetic Link Between Schizophrenia and CVD New Insight Into Genetic Link Between Schizophrenia and CVD
Researchers identify shared genetic loci between schizophrenia and cardiovascular disease risk factors, particularly smoking and body mass index.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 28, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news

Karuna Takes A Big Step In Schizophrenia Treatment. Shares Jump Higher
Karuna Therapeutics asked the Food and Drug Administration to approve its schizophrenia treatment on Thursday, and KRTX stock jumped higher. The post Karuna Takes A Big Step In Schizophrenia Treatment. Shares Jump Higher. appeared first on Investor's Business Daily.#krtx #jumphigher (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2023 Category: Consumer Health News Source Type: news

RAISE-ing the Standard of Care for Schizophrenia: The Rapid Adoption of Coordinated Specialty Care in the United States
The Recovery After an Initial Schizophrenia Episode research initiative, launched by NIMH to test the effectiveness of coordinated specialty care to treat first-episode psychosis, has transformed the mental health landscape in the United States and helped thousands of people with schizophrenia achieve better outcomes. (Source: National Institute of Mental Health)
Source: National Institute of Mental Health - September 28, 2023 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news

Dr. Jeffrey Lieberman's Title Malady of the Mind Makes the Amazon Best Seller List
Malady of the Mind: Schizophrenia and The Path To Prevention NEW YORK, Sept. 27, 2023 /PRNewswire-PRWeb/ -- Dr. Jeffrey A. Lieberman's book, Malady of the Mind: Schizophrenia and the Path to Prevention, has made the Amazon Best Seller List in the Psychiatry category. The book is a... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 27, 2023 Category: Pharmaceuticals Source Type: news

New Schizophrenia Treatments Are Coming: Don't Panic
(MedPage Today) -- At the recent Psych Congress 2023, a session titled "State of the Science: Focus on Schizophrenia" was presented by Peter J. Weiden, MD, a clinical professor of psychiatry at the Renaissance School of Medicine at Stony Brook... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 26, 2023 Category: Psychiatry Source Type: news

A cognitive-behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health: preliminary findings of an open pilot study - Bornheimer LA, Verdugo JL, Krasnick J, Jeffers N, Storey F, King CA, Taylor SF, Florence T, Himle JA.
Suicide is a leading cause of death among schizophrenia spectrum disorder populations. This open pilot study examined a modified cognitive-behavioral suicide prevention treatment for clients in community mental health. Providers (n=5) were trained to deliv... (Source: SafetyLit)
Source: SafetyLit - September 25, 2023 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Adverse Childhood Experiences Common in Schizophrenia
WEDNESDAY, Sept. 20, 2023 -- Patients with schizophrenia often have adverse childhood experiences (ACEs), according to a study published online Aug. 28 in Frontiers in Psychiatry. Lei Zhang, Ph.D., from Tongji University in Shanghai, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud?
(MedPage Today) -- Over half of people with schizophrenia experienced sexual dysfunction -- 55.7% of men and 60% of women -- according to a meta-analysis of more than 21,000 study participants. (JAMA Psychiatry) People who used both tobacco... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2023 Category: Psychiatry Source Type: news

Drug Trials Snapshot: LYBALVI
To treat schizophrenia and certain aspects of bipolar I disorder (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 19, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Risk of all-cause and suicide death in patients with schizophrenia: an entire-population longitudinal study in Taiwan - Cheng CM, Chang WH, Tsai SJ, Li CT, Tsai CF, Bai YM, Lin WC, Su TP, Chen TJ, Chen MH.
BACKGROUND: Schizophrenia increases mortality from all causes and specific causes. Comprehensive research on modifiable risk factors for early mortality from multiple sources is needed. METHODS: Taiwan's National Health Insurance Research Database,... (Source: SafetyLit)
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Cannabis Use and Relapse in First Episode Schizophrenia Cannabis Use and Relapse in First Episode Schizophrenia
This study investigates the association between cannabis use and relapse following a first-episode of psychosis. Can patients in remission after their first episode safely use cannabis?Schizophrenia Bulletin (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2023 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news